ABT
ABT
Indicative, may be delayed. Not trading-grade data.
Recently viewed
Only on this browser · up to 5Ticker detail
ABT
Cached quote, historical USD prices, and attributed headlines.
AI-generated
AI overview
Latest ABT headlines
- Abbott is mentioned alongside Dexcom amid U.S. wearables market growth [1]. - Abbott Laboratories is discussed in relation to an approaching breakup [2]. - Abbott is listed among companies in the HPV genotyping panels market report [3]. - Abbott is included in the point-of-care INR testing market report [4].
Generated Nov 01, 2026 · 07:34 UTC
- Dexcom Shakes Off Abbott-Tied Malaise As U.S. Wearables Market Takes Off — Yahoo Finance
- Can Abbott Laboratories (ABT) Stay Reasonable As Its Breakup Nears? — Yahoo Finance
- Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN — Yahoo Finance
- Capitol Hill's Top Trades: The Hottest Stocks Congress Is Trading Right Now — Yahoo Finance
- Point-of-Care International Normalized Ratio (INR) Testing Market Report 2026 | Secure 10.1% CAGR Gains as Abbott, Roche, Danaher and Siemens Healthineers Scale Home Monitoring — Yahoo Finance
Summary of the linked headlines, not full-article analysis. AI can make mistakes; verify the sources. Not investment advice.
Some history or news is missing or stale. Available cached data remains visible; background requests respect provider retry backoff. Reload this range to check again.
Historical price
23 observations · USD · Source: Yahoo Finance · Sep 30, 2026 · 13:30 UTC to Oct 30, 2026 · 13:30 UTC · latest observation may be incomplete.
News about ABT
- Dexcom Shakes Off Abbott-Tied Malaise As U.S. Wearables Market Takes Off ↗
- Can Abbott Laboratories (ABT) Stay Reasonable As Its Breakup Nears? ↗
- Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN ↗
- Capitol Hill's Top Trades: The Hottest Stocks Congress Is Trading Right Now ↗
- Point-of-Care International Normalized Ratio (INR) Testing Market Report 2026 | Secure 10.1% CAGR Gains as Abbott, Roche, Danaher and Siemens Healthineers Scale Home Monitoring ↗
- Perrigo exits infant-formula with sale to MeridianMade ↗
- AbbVie Stock: What 10 Years of Growth and Dividends Did for $1,000 ↗
- South & Central America Point of Care Diagnostics Market Size, Share, Trends and Forecast (2026-2031) Featuring Profiles of Siemens, Abbott Labs, Roche, bioMerieux, Bio-Rad Labs and More ↗
- What Is Behind The Move In Boston Scientific Stock? ↗
- Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease ↗
- What Have Medtronic Stock Holders Really Earned? ↗
- Should Steris Stock Holders Look At Medtronic Instead? ↗
- Apple Stock And Other Quality Growth Names For Higher Rates ↗
- Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact ↗
- What Could Abbott Laboratories (ABT) Spin Off Mean For Its Future Growth? ↗
- Europe Medical Foods Market Size, Share, Trends and Strategic Outlook, 2026-2033 Featuring Danone, Nestle, Abbott, Targeted Medical Pharma, Primus Pharma, Fresenius Kabi, Mead Johnson & Co. ↗
- What Would A Short Seller Say About Stryker? ↗
- Sector Update: Healthcare Stocks Decline Late Afternoon ↗
- Medtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks ↗
- Broadcom upgraded, HubSpot downgraded: Wall Street's top analyst calls ↗
Comments and bookmarks
Comments are plain text from NPDev accounts. Bookmarks stay private to the account that saved them.
No comments yet. Be the first to say something.
Sign in to join the conversation.